Cannabis Bioscience International Holdings, Inc.
CBIH
$0.00
$0.000.00%
OTC PK
| 02/28/2026 | 11/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -78.99% | 120.25% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -78.99% | 120.25% | |||
| Cost of Revenue | -71.43% | 29.63% | |||
| Gross Profit | -80.84% | 165.84% | |||
| SG&A Expenses | -26.84% | 52.64% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -29.91% | 50.61% | |||
| Operating Income | 2.71% | -28.21% | |||
| Income Before Tax | 11.20% | -41.65% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 11.20% | -41.65% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 11.20% | -41.65% | |||
| EBIT | 2.71% | -28.21% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -- | -- | |||
| Normalized Basic EPS | -- | -- | |||
| EPS Diluted | -- | -- | |||
| Normalized Diluted EPS | -- | -- | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||